Mitochondria: How the Relic from Biology Class Could be the Next Powerhouse for Biopharmaceutical Innovation

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Mitochondria are known as the powerhouses and energy hubs of the cell. Mostly relegated to biology textbooks, greater understanding of the role dysfunctional mitochondria play in numerous diseases, and their potential as a therapeutic target, is now emerging. Mitochondrial dysfunction contributes to the cardiac, ophthalmic and neurological symptoms of many rare diseases, Barth syndrome, Duchenne’s muscular dystrophy and ALS, to name a few.

Innovative medical developments are on the horizon to help meet the unmet medical needs of patients and address the costly burden of mitochondrial disease management. Attendees will walk away from this discussion with a better understanding of mitochondrial dysfunction in both rare genetic diseases and common diseases of aging.
Moderator
photo
Staff Writer
OneZero
Speakers
photo
Professor of Ophthalmology and Immunology
Duke Eye Center
photo
Chief Executive Officer
Stealth BioTherapeutics
photo
Executive Director
Barth Syndrome Foundation
photo
Staff Writer
OneZero
photo
Henry Ford Health System